SCHEMBL2408248

SCHEMBL2408248

CCCCCCCN(CCCc1csc(SC(C)(C)C(=O)ON(C2CCCCC2)C2CCCCC2)n1)C(=O)NC1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.41
PPARD Q03181 3/20 0.41
PPARA Q07869 3/20 0.41
MAPT P10636 2/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
USP1 O94782 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
NFKB1 P19838 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
BRCA1 P38398 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2413317 0.97 PPARA (0.43) PPARGPPARDPPARAMAPTGMNN
SCHEMBL12274269 0.88 PPARA (0.53) PPARGPPARDPPARAMAPTGMNN
SCHEMBL2408247 0.85 PPARA (0.53) PPARGPPARDPPARAMAPTGMNN
SCHEMBL2411949 0.84 PPARA (0.55) PPARGPPARDPPARAMAPTGMNN
SCHEMBL2413316 0.82 PPARA (0.55) PPARGPPARDPPARAMAPTGMNN
SCHEMBL12274271 0.76 PPARA (0.67) PPARGPPARDPPARAMAPTGMNN
SCHEMBL14452179 0.71 PPARG (0.39) PPARGPPARDPPARA
SCHEMBL2410256 0.70 HPGD (0.32) HPGD
SCHEMBL12277225 0.69 PPARG (0.36) PPARGPPARDPPARAMAPTGMNN
SCHEMBL2417110 0.69 PPARG (0.32) PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026370-B2 Peroxisome proliferator antagonist; hyperlipemia agents; arteriosclerosis; antiischemic agents MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-09-27 US disclosed
US-20080167307-A1 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof MITSUBISHI PHAMA CORPORATION (JP) 2008-07-10 US disclosed
EP-1816128-A1 CARBOXYLIC ACID DERIVATIVE CONTAINING THIAZOLE RING AND PHARMACEUTICAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2007-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167307-A1 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof PPARA, PPARD, PPARG PPARG 3/4885PPARD 2/4885PPARA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.